DIABETIC MACULAR EDEMA (DME)
Clinical trials for DIABETIC MACULAR EDEMA (DME) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC MACULAR EDEMA (DME) trials appear
Sign up with your email to follow new studies for DIABETIC MACULAR EDEMA (DME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug aims to save sight for diabetics
Disease control OngoingThis study is testing if a new eye injection called EYE103 is safe and effective at treating diabetic macular edema (DME), a common cause of vision loss in people with diabetes. It will compare two doses of EYE103 against a standard treatment (ranibizumab) in over 1,000 participa…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Head-to-Head eye injection study aims to find best treatment for diabetic vision loss
Disease control ENROLLING_BY_INVITATIONThis study compares two different eye injection medicines (aflibercept and bevacizumab) for treating diabetic macular edema, a common cause of vision loss in people with diabetes. Researchers will give 116 participants monthly injections for two months to see which medicine works…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: NA • Sponsor: CMH Multan Institute of Medical Sciences • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New eye injection trial aims to halt vision loss in common eye diseases
Disease control OngoingThis early-stage study is testing a new drug called EYE201, given as three injections into the eye, to see if it's safe and might help control vision loss. It's for adults with vision problems from diabetic macular edema, age-related macular degeneration, or a retinal vein blocka…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
Eye drop trial aims to save vision for diabetics
Disease control OngoingThis study is testing whether a new eye drop called KHK4951 can safely reduce swelling in the retina and improve vision for people with diabetic macular edema (DME). It involves about 150 adults with DME and compares the eye drops to a standard treatment. The main goal is to see …
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE2 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Researchers track Real-World eye treatment patterns
Knowledge-focused OngoingThis study looks back at existing health records to understand how doctors in Japan are using aflibercept 8 mg, an approved eye injection, to treat two common vision problems: age-related macular degeneration and diabetic macular edema. Researchers will analyze data from about 3,…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:36 UTC